These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Agranular CD4+ CD56+ hematodermic neoplasm: a new case report]. Chamaillard M, Beylot-Barry M, Viallard JF, Cogrel O, Vergier B, Pellegrin JL, Beylot C. Ann Dermatol Venereol; 2004 Dec; 131(12):1074-6. PubMed ID: 15692441 [Abstract] [Full Text] [Related]
49. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm. Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD. Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288 [Abstract] [Full Text] [Related]
50. [Blastic plasmacytoid dendritic cell neoplasm. Report of three cases]. Avilés-Salas A, Candelaria M, Ponce M, Cañavera-Constantino A, Burgos S. Rev Med Chil; 2017 Sep; 145(9):1208-1212. PubMed ID: 29424411 [Abstract] [Full Text] [Related]
51. CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma. Kim Y, Kang MS, Kim CW, Sung R, Ko YH. J Korean Med Sci; 2005 Apr; 20(2):319-24. PubMed ID: 15832009 [Abstract] [Full Text] [Related]
59. [Clinical Features of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm]. Wu LZ, Yu Q, Jiang Y, Peng HL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):307-313. PubMed ID: 32027294 [Abstract] [Full Text] [Related]